King Faisal Specialist Hospital and Research Centre
Saudi Arabia's flagship tertiary hospital, whose Oncology Centre runs the Gulf's largest transplant, CAR-T and proton therapy programmes.
Overview
King Faisal Specialist Hospital and Research Centre opened in Riyadh in 1975 and, with campuses in Jeddah and Madinah, is the leading referral hospital of Saudi Arabia and the wider Gulf. Its Oncology Centre and King Fahad National Centre for Children's Cancer deliver high-volume adult and paediatric cancer care, including one of the largest haematopoietic stem cell transplant programmes in the region, locally manufactured CAR-T therapy, robotic surgery, radioligand therapy and the first proton therapy facility in the Middle East, opened in Riyadh. The Research Centre hosts genomics under the Saudi Human Genome Program, cancer biology and clinical trials units, and the hospital houses the Saudi Cancer Registry's largest contributing service and pioneering work on thyroid, breast and hereditary cancers common in the Kingdom.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to King Faisal Specialist Hospital & Research Centre, including child institutions. 248 works · 2,114 citations · 75% open access · 10% clinical trials · 4% reviews.
- Mahmoud Deeb Aljurf41 works
- Shouki N. Bazarbashi19 works
- Riad Omar El Fakih18 works
- Abdulwahab A. Albabtain16 works
- Mohamed A. Kharfan‐Dabaja15 works
- Syed Osman Ahmed15 works
- Tusneem Ahmed M. Elhassan13 works
- Walid K. Rasheed12 works
- Mahmoud A. Elshenawy12 works
- Ali Debsan Alahmari12 works
- Oncology Centre and children's cancer centre
- Stem cell transplant and CAR-T
- Proton therapy
- Saudi Human Genome Program
Similar pages
not linked directly; found by shared links- InstitutionComprehensive Cancer Center Mainfranken, University Hospital Würzburg
Shares Diffuse large B-cell lymphoma, Radioligand therapy (beta emitters).
- InstitutionMD Anderson Cancer Center
- InstitutionUniversity Hospital Zurich / Comprehensive Cancer Center Zurich
Shares Diffuse large B-cell lymphoma, Radioligand therapy (beta emitters).
- InstitutionMemorial Sloan Kettering Cancer Center
- AgentRadioactive iodine (I-131)
- TechnologyRadioiodine therapy and whole-body iodine scanning
- RoadmapRadiopharmaceutical roadmap: iodine → lutetium → actinium
- BottleneckManufacturing cost and time for living and radioactive medicines
Shares Diffuse large B-cell lymphoma, Radioligand therapy (beta emitters).